Eurofins Discovery Email Format
Biotechnology ResearchMissouri, United States201-500 Employees
Eurofins Discovery is a biotechnology research company based at 15 Research Park Drive, St. Charles, Missouri 63304, United States. The company employs between 201 and 500 people. It has supported drug discovery research for more than 40 years, providing testing services and tools to help researchers accelerate the discovery and development of candidate molecules. Eurofins Discovery maintains a global team of scientists, information analysts, and client support professionals to enable improvements in human health and to expand its portfolio of testing methods and services. Recent developments include the February 2024 launch of DiscoveryAI SAFIRE, a suite of ADMET predictions for in silico refinement and evaluation, a 2024 collaboration with Dompé Farmaceutici S.p.A., and the March 2022 acquisition of Beacon Discovery, all reflecting growth within the Eurofins network of laboratories.